Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study

• Renzo Mignani,
• Federico Pieruzzi

Affiliations

Renzo Mignani

UO Nefrologia e Dialisi, Ospedale Infermi, Rimini, Italy; Corresponding author.

Federico Pieruzzi

Struttura Complessa di Nefrologia, ASST Monza - Ospedale San Gerardo, Italy